Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation of Alzheimer’s drugs — the first proven to change the course of the disease — work by tagging amyloid for […]
Immunotherapy for Alzheimer’s disease shows promise in mouse study
![](https://neuroscienceresearch.wustl.edu/files/2024/04/4-3-2024_Immunotherapy-for-Alzheimers-disease-shows-promise-in-mouse-study-d8a2d22422e2304b-350x233.jpg)